Cero Therapeutics Holdings, INC 8-K filings

Phoenix Biotech Acquisition Corp. stockholders voted to approve the merger with CERo Therapeutics, along with related proposals, at a special meeting held on February 8, 2024.

Phoenix Biotech Acquisition Corp. has amended its business combination agreement with CERo Therapeutics, Inc., removing the minimum cash condition and securing a $2 million PIPE financing.